{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:50:10Z","timestamp":1777719010882,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":5139,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.fertnstert.2007.05.002","type":"journal-article","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T07:21:07Z","timestamp":1183447267000},"page":"1221-1228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"89","author":[{"given":"\u00c5sa","family":"Lindholm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Bixo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger","family":"Bj\u00f6rn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"W\u00f6lner-Hanssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Eliasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owe","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger Sundstr\u00f6m","family":"Poromaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2007.05.002_bib1","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib2","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib3","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib6","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","author":"Solomon","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib8","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1042\/cs0980661","article-title":"Internal carotid artery haemodynamics in women with polycystic ovaries","volume":"98","author":"Lakhani","year":"2000","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib10","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(00)02764-1","article-title":"Internal carotid-artery response to 5% carbon dioxide in women with polycystic ovaries","volume":"356","author":"Lakhani","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.0000020681.19400.8A","article-title":"Impaired carotid viscoelastic properties in women with polycystic ovaries","volume":"106","author":"Lakhani","year":"2002","journal-title":"Circulation"},{"issue":"Suppl 5","key":"10.1016\/j.fertnstert.2007.05.002_bib12","first-page":"1353","article-title":"Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS)","volume":"14","author":"Macut","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.1993.tb01744.x","article-title":"The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women","volume":"39","author":"Pasquali","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2265.1994.tb02577.x","article-title":"Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables","volume":"41","author":"Holte","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2265.1996.674495.x","article-title":"Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries","volume":"44","author":"Robinson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib16","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-61-5-946","article-title":"Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome","volume":"61","author":"Wild","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0015-0282(97)00486-X","article-title":"The plasminogen activator system in women with polycystic ovary syndrome","volume":"69","author":"Atiomo","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2265.1996.00863.x","article-title":"Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome","volume":"45","author":"Sampson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/oxfordjournals.humrep.a019028","article-title":"Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?","volume":"11","author":"Holte","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib20","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome","volume":"80","author":"Holte","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib21","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib22","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1471-0528.2006.00966.x","article-title":"The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome\u2014a randomised, double-blind, placebo-controlled trial","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1345\/aph.18319","article-title":"Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity","volume":"33","author":"Luque","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib26","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa050156","article-title":"Randomized trial of lifestyle modification and pharmacotherapy for obesity","volume":"353","author":"Wadden","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-145-2-200607180-00005","article-title":"Effects of sibutramine treatment in obese adolescents: a randomized trial","volume":"145","author":"Berkowitz","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-277X.2004.00530.x","article-title":"What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions","volume":"17","author":"Avenell","year":"2004","journal-title":"J Hum Nutr Diet"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2007.05.002_bib29","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/sj.ejcn.1602172","article-title":"Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study","volume":"59","author":"Mathus-Vliegen","year":"2005","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2337\/diacare.28.6.1311","article-title":"Two-year outcome of a combination of weight loss therapies for type 2 diabetes","volume":"28","author":"Redmon","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib31","first-page":"207","article-title":"Metformin versus sibutramine in the treatment of hyperinsulinemia in chronically anovulating women","volume":"105","author":"Lazurova","year":"2004","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib32","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0015-0282(03)02162-9","article-title":"Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome","volume":"80","author":"Sabuncu","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib33","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/jc.2006-1327","article-title":"Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib34","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/humrep\/15.10.2098","article-title":"Prediction models for insulin resistance in the polycystic ovary syndrome","volume":"15","author":"Gennarelli","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib35","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s001250051561","article-title":"Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test","volume":"43","author":"Albareda","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1185\/030079905X38132","article-title":"A review of the metabolic effects of sibutramine","volume":"21","author":"Filippatos","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib37","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archpsyc.60.11.1109","article-title":"A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder","volume":"60","author":"Appolinario","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2007.05.002_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/humrep\/12.suppl_1.82","article-title":"Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome","volume":"12","author":"Pasquali","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","article-title":"The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy\u2014a review of the evidence","volume":"259","author":"Walldius","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib40","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1515\/CCLM.2004.254","article-title":"The apoB\/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk","volume":"42","author":"Walldius","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0889-8529(18)30240-8","article-title":"Plasma steroid\u2013binding proteins","volume":"20","author":"Rosner","year":"1991","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2004.10.029","article-title":"Sex hormone\u2013binding globulin is a major determinant of the lipid profile: the PRIME study","volume":"179","author":"Bataille","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib43","first-page":"283","article-title":"Interrelation between plasma sex hormone\u2013binding globulin and plasma insulin in healthy adult women: the telecom study","volume":"76","author":"Preziosi","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/00365510510013866","article-title":"Cystatin C: an emerging glomerular filtration rate marker","volume":"65","author":"Larsson","year":"2005","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","article-title":"Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease","volume":"145","author":"Shlipak","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib46","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/00365510510013839","article-title":"Increased serum cystatin C is associated with increased mortality in elderly men","volume":"65","author":"Larsson","year":"2005","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib48","article-title":"Long-term pharmacotherapy for obesity and overweight","author":"Padwal","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00002018-200629030-00008","article-title":"Early first-trimester sibutramine exposure: pregnancy outcome and neonatal follow-up","volume":"29","author":"De Santis","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejogrb.2004.02.035","article-title":"Exposure to sibutramine during pregnancy: a case series","volume":"116","author":"Einarson","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib51","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/bdra.20052","article-title":"Sibutramine use in pregnancy: report of two cases","volume":"70","author":"Kadioglu","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejogrb.2005.02.016","article-title":"Sibutramine in pregnancy","volume":"122","author":"Ramzi","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1071\/RD05030","article-title":"Fluoxetine during pregnancy: impact on fetal development","volume":"17","author":"Morrison","year":"2005","journal-title":"Reprod Fertil Dev"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib54","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00023210-200519070-00004","article-title":"SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome","volume":"19","author":"Gentile","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.fertnstert.2007.05.002_bib55","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2165\/00002018-200528070-00002","article-title":"Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant","volume":"28","author":"Nordeng","year":"2005","journal-title":"Drug Saf"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207010291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207010291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:23:17Z","timestamp":1758007397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028207010291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0015028207010291"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.05.002","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}